Press Release June 18, 2019: Orion Diagnostica appoints Juho Himberg as new CEO
Juho Himberg has been appointed new CEO of Orion Diagnostica. Currently the CEO of Orton, Juho Himberg starts in his new position on August 13th, 2019. Himberg has over 20 years of experience in international executive positions in the medtech and laboratory industries. Antti Koivula, Interim CEO since December 2018, will continue as CFO of Orion Diagnostica.
Orion Oyj sold Orion Diagnostica Oy to Axcel, a Nordic private equity company, in April 2018. Orion Diagnostica develops, manufactures and markets diagnostics point-of-care instruments and tests with a special expertise in infectious diseases, bone and soft tissue metabolism disorders and hygienic monitoring.
“Juho Himberg’s vast expertise in
international med-tech further strengthens Orion Diagnostica’s position
as a diagnostics expert and supports our international growth. Med-tech
is a growing, constantly developing industry. The importance of
promoting health and developing point-of-care diagnostics within
healthcare is becoming increasingly important”, says Rolf Classon, the Chairman of the Board at Orion Diagnostica.
Orion
Diagnostica’s strategic focus is on developing new innovative products
and international growth in existing and new markets. The company has a
strong position in the Nordic markets, Germany, Central Europe and
China, and is making significant inroads into the large US market.
“Orion
Diagnostica has a leading position in the Nordic markets as well as in
many markets internationally. Finnish med-tech is highly regarded around
the world. Juho Himberg is an excellent person to lead Orion
Diagnostica in its pursuit for further international growth”, says Thomas Blomqvist, Partner at Axcel.
“Orion
Diagnostica is a great example of Finnish med-tech succeeding in
competitive international markets. Orion Diagnostica is a successful
company and proud of its Finnish roots”, explains the newly appointed
CEO Juho Himberg.
Juho Himberg has been the CEO
of Orton since 2015. Prior to that, he worked in the international
medtech and laboratory industries for 20 years, of which 15 in
Switzerland. His background in Switzerland, the Netherlands and the US
is well aligned with Orion Diagnostica’s international growth goals.
“As
a stand-alone point-of-care specialized diagnostics company, Orion
Diagnostica focuses fully on developing products and services for
improving the well-being and the quality of life for people around the
world. Our easy-to-use tests provide rapid, high quality and
cost-effective results”, Himberg continues.
“In 2019, in
addition to its growth goals, Orion Diagnostica has many important
milestones with easy CRP and HbA1c launches and FDA approval in the US”,
Classon concludes.
For more information
Juho Himberg, Mob: +358 40 660 5343
Rolf Classon, Chairman of the Board, Orion Diagnostica, Mob: +1 (914) 320 1188
Thomas Blomqvist, Partner, Axcel, Mob: +46 (709) 22 10 49
Orion Diagnostica
Orion
Diagnostica is a leading point-of-care diagnostics company. Orion
Diagnostica develops, manufactures and markets a range of reliable and
easy to use instruments and tests. Through its sales force and
high-quality distributor network, Orion Diagnostica delivers its
innovative product range to healthcare practitioners in some 60
countries worldwide. Orion Diagnostica has an installed base over 50.000
QuikRead® and QuikRead go® instruments worldwide. The company has
around 300 employees and is headquartered in Espoo, Finland.
Axcel Management
Axcel
is a leading Nordic private equity firm in the mid-cap market with a
focus on investing in strong Nordic market leaders. Since its inception
over 25 years ago, Axcel has invested in well over 50 Nordic companies
as well as consummated over 100 add-on acquisitions in the Nordic region
and beyond.